Hostname: page-component-8448b6f56d-xtgtn Total loading time: 0 Render date: 2024-04-20T09:49:30.125Z Has data issue: false hasContentIssue false
  • English
  • Français

Electro-convulsive therapy in neuroleptic malignant syndrome

Published online by Cambridge University Press:  16 April 2020

MZ Azhar  and
SL Varma
MZ Azhar
Affiliation:
Department of Psychiatry, University Science Malaysia Hospital, 16150Kubang Kerian Kelantan, Malaysia
SL Varma
Affiliation:
Department of Psychiatry, University Science Malaysia Hospital, 16150Kubang Kerian Kelantan, Malaysia

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A middle aged lady having Manic-depressive psychosis developed neuroleptic malignant syndrome (NMS) on haloperidol. The emergent psychosis after recovery from NMS resolved with judicious use of electro-convulsive therapy (ECT) followed by gradual reintroduction of antipsychotics is reported here.

Type
Letter to the editor
Information
European Psychiatry , Volume 10 , Issue 2 , 1995 , pp. 111
Copyright
Copyright © Elsevier, Paris 1995

References

Meltzer, HYRigidity, hyperpyrexia and out come following fleuphenazine enanthate. Psychopharmacology 1973; 29: 337–46CrossRefGoogle Scholar
Peet, MCollier, JUse of carbamazapine in psychosis after NMS. Br J Psychiatry 1990; 156: 579–81CrossRefGoogle Scholar
Shalev, AManitz, HThe neuroleptic malignant syndrome: agent and host interaction. Acta Psychiatr Scand 1986; 73: 337–47CrossRefGoogle ScholarPubMed
Stoudmoire, ALauther, JSNMS and neuroleptic induced catatonia. Int J Psychiatry Med 1989; 14: 57–63Google Scholar
Wells, ALSommi, RWCrisman, MLNeuroleptic rechallenge of NMS. Drug Intell Clin Pharm 1988; 22: 457–79Google Scholar
Submit a response

Comments

No Comments have been published for this article.